<?xml version="1.0" encoding="UTF-8"?>
<p id="para0036">Notable among various interventions is the use of dexamethasone, which was found to reduce 28-day mortality modestly in those requiring respiratory support in the RECOVERY study 
 <xref rid="bib0069" ref-type="bibr">[69]</xref>. Thus far, dexamethasone is the only drug shown to reduce COVID-19 mortality (
 <xref rid="tbl0001" ref-type="table">Table 1</xref>). Details of empiric and general therapies are not discussed given the focus of this review on specific anti-viral therapy.
</p>
